Back to Agenda
AM
Speaker(s)
![Hiroyuki Sakamaki, DrSc, PhD, MBA](/_Images/member/Generic_Image_Missing-Profile.jpg)
Can cost-effectiveness assessment be useful for the drug price policy reform?
Hiroyuki Sakamaki, DrSc, PhD, MBA
Kanagawa University of Human Services, Japan
Professor, School of Health Innovation
![Haruko Noguchi](/_Images/member/Generic_Image_Missing-Profile.jpg)
HEOR - from academia's perspective
Haruko Noguchi
Waseda University, Japan
Professor, Faculty of Political Science and Economics
![Tsuguo Iwatani](/_Images/member/Generic_Image_Missing-Profile.jpg)
HEOR - from a clinician's perspective
Tsuguo Iwatani
St. Marianna University School of Medicine, Japan
Breast and Endocrine Surgery
Have an account?